Ratings
0
Nobody has rated this yet. Be the first!
Works
8
Addition of a 161-SNP polygenic risk score to family history-based risk prediction: impact on clinical management in non-BRCA1/2 breast cancer families
Clustering of known low and moderate risk alleles rather than a novel recessive high-risk gene in non-BRCA1/2 sib trios affected with breast cancer
Homozygosity for aCHEK2*1100delC mutation identified in familial colorectal cancer does not lead to a severe clinical phenotype
Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics
Intronic variants in BRCA1 and BRCA2 that affect RNA splicing can be reliably selected by splice-site prediction programs
The CHEK2*1100delC variant acts as a breast cancer risk modifier in non-BRCA1/BRCA2 multiple-case families
Breast Cancer Susceptibility—Towards Individualised Risk Prediction
The functional impact of variants of uncertain significance in BRCA2
